Southland Equity Partners LLC Eli Lilly & CO Transaction History
Southland Equity Partners LLC
- $350 Billion
- Q2 2024
A detailed history of Southland Equity Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Southland Equity Partners LLC holds 313 shares of LLY stock, worth $247,335. This represents 0.08% of its overall portfolio holdings.
Number of Shares
313
Previous 560
44.11%
Holding current value
$247,335
Previous $436 Million
35.0%
% of portfolio
0.08%
Previous 0.12%
Shares
5 transactions
Others Institutions Holding LLY
# of Institutions
3,775Shares Held
736MCall Options Held
7.09MPut Options Held
7.23M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$76.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$57.5 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$51.6 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$40.6 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$27.1 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $751B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...